Clinical Trials Directory

Trials / Completed

CompletedNCT05221255

Effect of Spinal Magnetic Stimulation on Management of Functional Constipation in Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Alexandria · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

conservative management of functional constipation is a preferable method including biofeedback and spinal magnetic stimulation sessions

Detailed description

Constipation varies in presentation and severity among patients and affects patients' quality of life of varied degrees depending on how it manifests and how severe it is. The prevalence of constipation in the general population is estimated to affect about 20% of the population Spinal Magnetic Stimulation (SMS) is a non-invasive, painless neurophysiological treatment that uses extracorporeal magnetic stimulation to direct extracorporeal magnetic stimulation to the spinal nerves and deep muscles to aid bowl evacuation without the use of surgery. This noninvasive approach was created to help with micturition, expiration, and bowel function The aim of this work is to study the efficacy of SMS and biofeedback versus biofeedback in the management of functional constipation.

Conditions

Interventions

TypeNameDescription
OTHERspinal magnetic stimulation* Biofeedback pelvic floor muscle training sessions will be performed for both groups for a total of 12 sessions. Menstruating women will be temporarily withdrawn from BF sessions till end of the menses. The session will last for 30 minutes of transrectal pressure biofeedback relaxation technique. Auditory and visual feedback will be provided in addition to positive verbal reinforcement. * Sham SMS will be used in the Sham group using the placebo program in the magnetic stimulation machine. * Spinal magnetic stimulation using the Neuro-MS/D machine. It will be used in spinal magnetic stimulation group, circular coil will be used to stimulate S2,3 and 4 sacral roots. Intensities will be adjusted to 50-70 % of maximal output (2.2 Tesla), stimulation frequency will be fixed at 20 Hz, burst length = 5 seconds, inter-burst interval = 25 seconds.

Timeline

Start date
2022-01-01
Primary completion
2022-10-01
Completion
2022-10-01
First posted
2022-02-02
Last updated
2024-05-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05221255. Inclusion in this directory is not an endorsement.